Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50–64 years old in the United States

•We found relatively low rates of recombinant zoster vaccine (RZV) series initiation.•There were lower rates of RZV initiation among men, those living in rural areas and in the Northeast and the South, and those of younger age.•Initiation rates differed by immune function (higher among immunocomprom...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2023-01, Vol.41 (1), p.49-60
Hauptverfasser:	Fix, Jonathan, Vielot, Nadja A., Lund, Jennifer L., Weber, David J., Smith, Jennifer S., Hudgens, Michael G., Becker-Dreps, Sylvia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adults Age Cancer Chicken pox Codes Complications Contraindications Demographics Demography Disease control Dosage Drug dosages Female Health care Health maintenance organizations Hematology Herpes zoster Herpes Zoster - epidemiology Herpes Zoster - prevention & control Herpes Zoster Vaccine Herpesvirus 3, Human HIV HIV Infections - complications HMOs Human immunodeficiency virus Humans Immune Function Immune response Immune status Immunocompetence Immunosuppression Insurance coverage Malignancy Medical practices Middle Aged Outpatient care facilities Patterns of Use Population Prescription drugs Primary immunodeficiencies Recombinant Zoster Vaccine Transplants & implants United States - epidemiology Vaccination Vaccines Vaccines, Synthetic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!